Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Where this comes from

• Record sourced from PubMed, PMID 41838633.
• Also identified by DOI 10.1371/journal.pone.0344953 and PMC identifier 12991218.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.